DUPONT CAPITAL MANAGEMENT CORP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$582,532
-22.1%
4,118
-7.3%
0.03%
-19.4%
Q1 2023$747,687
-16.5%
4,441
-16.1%
0.04%
-14.3%
Q4 2022$895,819
-15.9%
5,291
-7.0%
0.04%
-33.3%
Q3 2022$1,065,000
-2.8%
5,692
-15.6%
0.06%
+23.5%
Q2 2022$1,096,000
+13.1%
6,748
+30.9%
0.05%
+30.8%
Q1 2022$969,000
-49.1%
5,154
-28.3%
0.04%
-42.6%
Q4 2021$1,904,000
-15.5%
7,190
-7.8%
0.07%
-4.2%
Q3 2021$2,254,000
+249.5%
7,800
+141.3%
0.07%
+373.3%
Q2 2021$645,000
+2.5%
3,2330.0%0.02%0.0%
Q1 2021$629,000
-11.9%
3,233
-13.3%
0.02%0.0%
Q4 2020$714,000
+29.8%
3,7270.0%0.02%
+25.0%
Q3 2020$550,000
+7.0%
3,727
-10.3%
0.01%
+9.1%
Q2 2020$514,000
+27.5%
4,155
-0.6%
0.01%
+10.0%
Q1 2020$403,000
-48.9%
4,179
-51.0%
0.01%
-44.4%
Q4 2019$789,000
+101.8%
8,528
+67.2%
0.02%
+100.0%
Q3 2019$391,000
-9.3%
5,100
-64.1%
0.01%
+12.5%
Q1 2015$431,000
+56.7%
14,202
+2.2%
0.01%
+60.0%
Q4 2014$275,000
-69.3%
13,892
-69.2%
0.01%
-68.8%
Q3 2014$897,000
-12.6%
45,0320.0%0.02%
-5.9%
Q2 2014$1,026,000
+77.2%
45,0320.0%0.02%
+88.9%
Q1 2014$579,000
-5.7%
45,0320.0%0.01%
-18.2%
Q4 2013$614,00045,0320.01%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 795,433$148,833,00013.13%
Miura Global Management 53,800$10,067,0006.03%
Brown Capital Management 1,740,034$325,578,0004.56%
Iron Triangle Partners LP 100,000$18,711,0003.27%
LRT Capital Management, LLC 22,652$4,238,0002.89%
AWM Investment Company, Inc. 100,000$18,711,0002.84%
Ranger Investment Management 188,944$35,353,0002.78%
Conestoga Capital Advisors, LLC 681,063$127,434,0002.49%
Ally Bridge Group (NY) LLC 16,724$3,129,0002.07%
Stephens Investment Management Group LLC 542,598$101,526,0001.92%
View complete list of REPLIGEN CORP shareholders